Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter updates include Revision: v3.3.3; removal of the HHS Vulnerability Disclosure link and the older Revision: v3.3.2 reference.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.3.1. No changes to study details or other page content.SummaryDifference0.1%

- Check39 days agoChange DetectedPublications section updated: added notes that publications are provided voluntarily and auto-filled from PubMed, and the revision tag is now v3.3.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe funding-status notice regarding government operations has been removed from the page; core study details, eligibility criteria, and results information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedUpdated Study Record Dates and last update timestamp; core study content including condition, intervention, eligibility criteria, endpoints, and results remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange DetectedPage now displays a new version (v3.2.0) and includes a government-operating-status notice; the old version tag (v3.1.0) was removed.SummaryDifference1%

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.